International Journal of Stroke/journals.sagepub.com
Jul 31, 2026, 16:37
No Clear Benefit of Short-Term Dual Antiplatelet Therapy in TIA or Stroke Without ≥50% Stenosis – International Journal of Stroke
International Journal of Stroke shared a post on LinkedIn about a recent article by Mateus Kist Ibiapino et al., adding:
”New meta-analysis
In patients with TIA or ischemic stroke without at least 50 percent large-artery stenosis, the benefit of short-term dual antiplatelet therapy is uncertain and may come with a higher bleeding risk.”
Title: Dual Antiplatelet Therapy in Stroke Without Stenotic Atherosclerosis: A Meta-Analysis with Trial Sequential Analysis
Authors: Mateus Kist Ibiapino, Marwa Ibrahim, Vanisha Kumar, Diana Lissie Mamani-Sucari, Sofia Zuppi Sardinha Mantovani, Igor Haitovich, Leonardo Caetano Borgomanero, Gisele Sampaio Silva
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?